TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33932320

Group type: EXPERIMENTAL
Intervention: internet-based attention bias modification (iABM), 5 sessions over 1 month
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 300
Study: 33892754

Group type: EXPERIMENTAL
Intervention: Robotic gait training targeting paretic propulsion (ten 60‐min sessions, five weeks, twice a week)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Robotic gait training targeting paretic propulsion
Number of subjects: 29
Study: 616875265

Group type: EXPERIMENTAL
Intervention: Nominal monetary incentive during or 1 month after the stay
Number of subjects: 285
Study: 35350436

Group type: EXPERIMENTAL
Intervention: Tenofovir/Levonorgestrel Vaginal Ring (IVR)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo IVR
Number of subjects: 47
Study: 33517746

Group type: EXPERIMENTAL
Intervention: Online education programme (ED)
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Contact through simulated contact with people with dementia and carers (CT)
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Education and contact (ED+CT)
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 1024
Study: 35713504

Group type: EXPERIMENTAL
Intervention: Post-reopening abortion care services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-reopening abortion care clients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pre-closure abortion care services
Number of subjects: 0
Study: 32169363

Group type: EXPERIMENTAL
Intervention: Gliadel Wafer and DC vaccination
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: DC vaccination
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Gliadel Wafer placement
Number of subjects: 28
Study: 35144699

Group type: EXPERIMENTAL
Intervention: Fish oil (FO, 5.2 g/d n‐3PUFA)
Number of subjects: 26
Study: 34429095

Group type: EXPERIMENTAL
Intervention: Do not interrupt vest (experimental group)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control group (no vest)
Number of subjects: 178
Study: 35500961

Group type: EXPERIMENTAL
Intervention: Dynamic lumbar motor control training (MCT) for 8 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: General trunk-training for 8 weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Dynamic lumbar motor control training (MCT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: General trunk-training
Number of subjects: 19
Study: 32293517

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Virtual Reality Hypnosis (VRH)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control
Number of subjects: 100
Study: 33927251

Group type: EXPERIMENTAL
Intervention: Large reward
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reward
Number of subjects: 0

Group type: COMPARATOR
Intervention: Punishment
Number of subjects: 0
Study: 34287673

Group type: EXPERIMENTAL
Intervention: Choline chloride
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Choline bitartrate
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: α‐glycerophosphocholine (GPC)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Egg-PC
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 6
Study: 33482387

Group type: EXPERIMENTAL
Intervention: VOM ethanol infusion combined with catheter ablation (CA)
Number of subjects: 343

Group type: COMPARATOR
Intervention: CA alone
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: VOM ethanol infusion combined with CA
Number of subjects: 343
Study: 34871514

Group type: EXPERIMENTAL
Intervention: Open lung ventilation strategy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard ventilation
Number of subjects: 40
Study: 34590746

Group type: EXPERIMENTAL
Intervention: Once-daily omeprazole (1 mg/kg)
Number of subjects: 14
Study: 35430521

Group type: EXPERIMENTAL
Intervention: Financial incentives of unspecified amount
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Financial incentives of $20
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Financial incentives of $60
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Financial incentives of $100
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Entire incentive at first clinical visit
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Factors associated with entire incentive at first clinic visit
Number of subjects: 635
Study: 33863352

Group type: EXPERIMENTAL
Intervention: CT-P13 SC
Number of subjects: 949
Study: 32963266

Group type: EXPERIMENTAL
Intervention: NGF + lidocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: NGF + IS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Isotonic saline (IS)
Number of subjects: 60
Study: 34306601

Group type: EXPERIMENTAL
Intervention: Smart medical nursing intervention
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine nursing method (Control)
Number of subjects: 80
Study: 33038502

Group type: EXPERIMENTAL
Intervention: Lanifibranor (800 and 1200 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35771621

Group type: EXPERIMENTAL
Intervention: Computer-based brief alcohol intervention consisting of 3 individualized feedback letters sent via mail at baseline, month 3, and month 6.
Number of subjects: 1646

Group type: COMPARATOR
Intervention: Assessment only (control group)
Number of subjects: 1646
Study: 34408110

Group type: EXPERIMENTAL
Intervention: Intravascular laser irradiation of blood (ILIB) for 10 min
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Laser acupuncture for 40 s over points VG20 (Baihui), PC6 (Neiguan), and the Oppression Point
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham laser irradiation of three acupuncture points
Number of subjects: 84
Study: 34881670

Group type: EXPERIMENTAL
Intervention: Additional resistance/balance training (3 days/week) during phase‐II CR and telephone‐support program during 3-month follow‐up.
Number of subjects: 116

Group type: COMPARATOR
Intervention: Usual CR care.
Number of subjects: 116
Study: 32083990

Group type: EXPERIMENTAL
Intervention: Docetaxel 75 mg/m2 intravenously plus oral capecitabine 825 mg/m2 two times per day for 14 days every 3 weeks for 6 cycles (DC)
Number of subjects: 1301

Group type: COMPARATOR
Intervention: Standard anthracycline-based regimens, with or without taxanes (control)
Number of subjects: 1301

Group type: EXPERIMENTAL
Intervention: Docetaxel-capecitabine (DC)
Number of subjects: 1301

Group type: COMPARATOR
Intervention: Standard anthracycline-based regimens (control)
Number of subjects: 1301
Study: 35008008

Group type: EXPERIMENTAL
Intervention: SCIG 20% biweekly (dose adjustment factor 1.0 or 1.37)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: SCIG 20% weekly and biweekly
Number of subjects: 95

Group type: COMPARATOR
Intervention: IVIG 10% every 3 or 4 weeks
Number of subjects: 95
Study: 34476095

Group type: EXPERIMENTAL
Intervention: Vitamin K supplementation (menaquinone-7, 360 µg daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 33564963

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) ingestion post-exercise
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo beverage post-exercise
Number of subjects: 8
Study: 32716645

Group type: EXPERIMENTAL
Intervention: Prosocial video game for 30 minutes
Number of subjects: 60

Group type: COMPARATOR
Intervention: Neutral video game for 30 minutes
Number of subjects: 60
Study: 34175554

Group type: EXPERIMENTAL
Intervention: Race-related stressor
Number of subjects: 52

Group type: COMPARATOR
Intervention: General stressor
Number of subjects: 52
Study: 32363743

Group type: EXPERIMENTAL
Intervention: 10 mg enalapril and 0.8 mg folic acid
Number of subjects: 14943

Group type: COMPARATOR
Intervention: 10 mg enalapril alone
Number of subjects: 14943
Study: 34115697

Group type: EXPERIMENTAL
Intervention: Velocity Loss 40% (VL40)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Velocity Loss 20% (VL20)
Number of subjects: 30
Study: 34896068

Group type: EXPERIMENTAL
Intervention: Structured recommendations and electronic tracking (post-intervention)
Number of subjects: 1301

Group type: COMPARATOR
Intervention: No structured recommendations (pre-intervention)
Number of subjects: 1301
Study: 33236826

Group type: EXPERIMENTAL
Intervention: Salt bath + UVB
Number of subjects: 2105

Group type: COMPARATOR
Intervention: UVB alone
Number of subjects: 2105
Study: 34473544

Group type: EXPERIMENTAL
Intervention: Nivolumab (240 mg once every 2 weeks)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Gemcitabine (GEM 1000 mg/m2 for 30 minutes on days 1, 8, and 15) or Pegylated Liposomal Doxorubicin (PLD 50 mg/m2 once every 4 weeks)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Gemcitabine (GEM) or Pegylated Liposomal Doxorubicin (PLD)
Number of subjects: 316
Study: 33399989

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 33741048

Group type: EXPERIMENTAL
Intervention: Order set change and facilitation training (2-day workshop with antibiotic stewardship teams)
Number of subjects: 0
Study: 32937045

Group type: EXPERIMENTAL
Intervention: Belimumab (10 mg/kg body weight) plus standard therapy
Number of subjects: 448

Group type: COMPARATOR
Intervention: Placebo plus standard therapy
Number of subjects: 448
Study: 33597056

Group type: EXPERIMENTAL
Intervention: 30 g milk protein (MILK)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 30 g wheat protein (WHEAT)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: 30 g blend of 15 g wheat plus 15 g milk protein (WHEAT+MILK)
Number of subjects: 36
Study: 33040782

Group type: EXPERIMENTAL
Intervention: Tuling Wendan Decoction combined with flunarizine
Number of subjects: 96

Group type: COMPARATOR
Intervention: Flunarizine
Number of subjects: 96
Study: 35419083

Group type: EXPERIMENTAL
Intervention: Low-dose CT enterography (CTE) based on modified guided image filtering (GIF) algorithm
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine CT examination (Control group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CTE in the diagnosis of UC and CD
Number of subjects: 120
Study: 34428740

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 95

Group type: COMPARATOR
Intervention: Non-Metformin
Number of subjects: 95
Study: 35644335

Group type: EXPERIMENTAL
Intervention: Prophylactic IVC filters
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prophylactic anticoagulation therapy delay
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Duration of filter left in situ
Number of subjects: 100
Study: 32893536

Group type: EXPERIMENTAL
Intervention: Jinye Baidu Granules, 10 g/time, three times a day for 5 days
Number of subjects: 606

Group type: COMPARATOR
Intervention: Compound Shuanghua Granules placebo, 6 g/time, four times a day for 5 days
Number of subjects: 606

Group type: EXPERIMENTAL
Intervention: Jinye Baidu Granules
Number of subjects: 606

Group type: COMPARATOR
Intervention: Compound Shuanghua Granules
Number of subjects: 606
Study: 35227365

Group type: EXPERIMENTAL
Intervention: High aesthetic-color flyer
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: High aesthetic-black-and-white flyer
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Low aesthetic-color flyer
Number of subjects: 204

Group type: COMPARATOR
Intervention: Low aesthetic-black-and-white flyer
Number of subjects: 204
Study: 35689729

Group type: EXPERIMENTAL
Intervention: TF-CBT + AAT
Number of subjects: 33

Group type: COMPARATOR
Intervention: TF-CBT alone
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: TF-CBT + AAT and TF-CBT alone
Number of subjects: 33
Study: 34001414

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nitrous Oxide (N2O)
Number of subjects: 35
Study: 32723754

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing plus Standard Educational Care (MI+SEC)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard Educational Care (SEC)
Number of subjects: 47
Study: 35841043

Group type: EXPERIMENTAL
Intervention: Tailored implementation support for PainManager CDS tool
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PainManager CDS tool
Number of subjects: 0
Study: 33485608

Group type: EXPERIMENTAL
Intervention: 150 mg Depo-Provera (n = 24)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 300 mg Depo-Provera (n = 9)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Depo-SubQ Provera 104 (two injections, n = 9)
Number of subjects: 42
Study: 32209897

Group type: EXPERIMENTAL
Intervention: Single-port laparoscopic surgery (SPLS)
Number of subjects: 388

Group type: COMPARATOR
Intervention: Multiport laparoscopic surgery (MPLS)
Number of subjects: 388
Study: 32524605

Group type: EXPERIMENTAL
Intervention: Intervention package including promotional materials, education for traditional birth attendants, and provider capacity building.
Number of subjects: 24412

Group type: EXPERIMENTAL
Intervention: Intervention package
Number of subjects: 24412
Study: 36357289

Group type: EXPERIMENTAL
Intervention: Comparative probe (asking participants to compare which vaccine to take)
Number of subjects: 1736

Group type: COMPARATOR
Intervention: Deliberative probe (asking participants whether they would like to take the vaccine)
Number of subjects: 1736

Group type: EXPERIMENTAL
Intervention: Comparative probe among Pro-Trump Republicans
Number of subjects: 1736
Study: 34007017

Group type: EXPERIMENTAL
Intervention: Docetaxel + ADT
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control (ADT only)
Number of subjects: 177
Study: 32495329

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP), 6-month intervention, 3 times a week, 45 minutes per session
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Otago Exercise Program (OEP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study: 33759701

Group type: EXPERIMENTAL
Intervention: Creatine and Caffeine (CR-CAF)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Creatine (CR)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Caffeine (CAF)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 28
Study: 33893738

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Sham procedure (Control)
Number of subjects: 99
Study: 35393245

Group type: EXPERIMENTAL
Intervention: Calcium score PSN
Number of subjects: 3556

Group type: COMPARATOR
Intervention: Contemporary PTP score incorporating calcium score and risk factors
Number of subjects: 3556
Study: 34588952

Group type: EXPERIMENTAL
Intervention: 40 mg/day istradefylline
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33269394

Group type: EXPERIMENTAL
Intervention: Regular consumption of safe live microbes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary recommendations for live microbes
Number of subjects: 0
Study: 35684031

Group type: EXPERIMENTAL
Intervention: Micronutrient powders (MNP)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Syrup
Number of subjects: 54

Group type: COMPARATOR
Intervention: Fortified food (FF)
Number of subjects: 54
Study: 34224382

Group type: EXPERIMENTAL
Intervention: Stent optimization using high-definition intravascular ultrasound (HD-IVUS)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Angiography-guided stenting (AGS)
Number of subjects: 29
Study: 32472836

Group type: EXPERIMENTAL
Intervention: Blue light therapy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Amber light therapy
Number of subjects: 35
Study: 34802879

Group type: EXPERIMENTAL
Intervention: Platinum combination chemotherapy plus pembrolizumab
Number of subjects: 422

Group type: COMPARATOR
Intervention: Platinum combination chemotherapy plus nivolumab and ipilimumab
Number of subjects: 422
Study: 34753515

Group type: EXPERIMENTAL
Intervention: Sugammadex
Number of subjects: 120

Group type: COMPARATOR
Intervention: Neostigmine
Number of subjects: 120
Study: 36214414

Group type: EXPERIMENTAL
Intervention: Resilient Parenting for Bereaved Families program (RPBF)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 74
Study: 32673002

Group type: EXPERIMENTAL
Intervention: Deliberate Practice (DP) workshop
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control workshop (traditional non-DP)
Number of subjects: 88
Study: 36411723

Group type: EXPERIMENTAL
Intervention: Everolimus plus reduced tacrolimus (EVR+rTAC)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Standard tacrolimus (sTAC)
Number of subjects: 117
Study: 32049191

Group type: EXPERIMENTAL
Intervention: Synbiotic substance (Frutooligossacaride 6g, Lactobacillus paracasei LPC‐31 10^9 to 10^8 UFC, Lactobacillus rhamnosus HN001 10^9 to 10^8 UFC, Lactobacillus acidophilus NCFM 10^9 to 10^8 UFC, Bifidobacterium lactis HN019 10^9 to 10^8 UFC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 35522626

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention for GPs including a workshop on appropriate prescribing of BZDs, tapering-off long-term BZD use, monthly BZD prescription feedback, and access to a support web page.
Number of subjects: 749

Group type: COMPARATOR
Intervention: Control group (standard care).
Number of subjects: 749

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention for GPs.
Number of subjects: 749
Study: 33860592

Group type: EXPERIMENTAL
Intervention: Milestone Communication Approach (MCA)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Standard oncological care
Number of subjects: 174
Study: 36075233

Group type: EXPERIMENTAL
Intervention: VLA2001 (0.5 mL; 33 antigen units per dose)
Number of subjects: 4017

Group type: COMPARATOR
Intervention: ChAdOx1-S (0.5 mL; 2.5 x 10^8 infectious units per dose)
Number of subjects: 4017

Group type: EXPERIMENTAL
Intervention: VLA2001 (open-label for participants aged 18-29 years)
Number of subjects: 4017

Group type: EXPERIMENTAL
Intervention: VLA2001 (randomised for participants aged 30 years and older)
Number of subjects: 4017
Study: 33673068

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous Needle Electrolysis (PNE)
Number of subjects: 0
Study: 33622700

Group type: EXPERIMENTAL
Intervention: Primary KPro
Number of subjects: 82

Group type: COMPARATOR
Intervention: Secondary KPro
Number of subjects: 82
Study: 34413795

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitors (SSRIs)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Psycho-Education (PE)
Number of subjects: 123
Study: 32563539

Group type: EXPERIMENTAL
Intervention: Topical anesthetic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical placebo
Number of subjects: 0
Study: 35300932

Group type: EXPERIMENTAL
Intervention: ERR-10 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: ERR-14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NERR-14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: NERR-21 days
Number of subjects: 0
Study: 32160504

Group type: EXPERIMENTAL
Intervention: US-guided subacromial corticosteroid and LA injection
Number of subjects: 29

Group type: COMPARATOR
Intervention: Blind subacromial corticosteroid and LA injection
Number of subjects: 29
Study: 35395383

Group type: EXPERIMENTAL
Intervention: Modified Glasgow prognostic score (mGPS) based on plasma C-reactive protein (CRP) and albumin levels.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline muscle or adipose tissue parameters during 12 weeks of treatment.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eastern Cooperative Oncology Group performance status together with CRP or mGPS.
Number of subjects: 0
Study: 33023185

Group type: EXPERIMENTAL
Intervention: rTSST-1v vaccine
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 34218960

Group type: EXPERIMENTAL
Intervention: Hillchol
Number of subjects: 560

Group type: COMPARATOR
Intervention: Shanchol
Number of subjects: 560
Study: 32027441

Group type: EXPERIMENTAL
Intervention: Antibiotics (280 patients)
Number of subjects: 418

Group type: COMPARATOR
Intervention: No antibiotics (138 patients)
Number of subjects: 418
Study: 34802352

Group type: EXPERIMENTAL
Intervention: START intervention
Number of subjects: 99

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 99
Study: 33895032

Group type: EXPERIMENTAL
Intervention: Nonoperative treatment for patellar fractures; 23 cases treated nonoperatively.
Number of subjects: 2954

Group type: EXPERIMENTAL
Intervention: Operative treatment for patellar fractures; 9 cases treated operatively.
Number of subjects: 2954

Group type: EXPERIMENTAL
Intervention: Preoperative HSS score compared to postoperative HSS score.
Number of subjects: 2954

Group type: EXPERIMENTAL
Intervention: Complications after treatment for patellar fractures.
Number of subjects: 2954

Group type: COMPARATOR
Intervention: Comparison of treatment results based on treatment method and fracture type.
Number of subjects: 2954
Study: 32967495

Group type: EXPERIMENTAL
Intervention: Ligation of the intersphincteric fistula tract (LIFT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Traditional anal fistulectomy
Number of subjects: 90
Study: 36006761

Group type: COMPARATOR
Intervention: Single-vision contact lenses (SVCL)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Extended depth of focus contact lenses (EDOF)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: MiSight® contact lenses
Number of subjects: 95
Study: 32222935

Group type: EXPERIMENTAL
Intervention: SALAS score assessment during the entire operation (group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SALAS score assessment during the 2nd and 3rd quartile of the operation (group B)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Interrater reliability of the SALAS score
Number of subjects: 20

Group type: COMPARATOR
Intervention: Correlation between operation time and SALAS score
Number of subjects: 20
Study: 34350055

Group type: EXPERIMENTAL
Intervention: Toe clearance rehabilitative slippers (top-weighted with a lead bead of 200, 300, or 400 g), worn for 10-20 min, 1-3 days/week for 12 months.
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 59
Study: 32583931

Group type: EXPERIMENTAL
Intervention: 10,000 lux bright light therapy (BLT) for 30 minutes in the morning for 14 consecutive days
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Dim light bright light therapy (BLT) for 30 minutes in the morning for 14 consecutive days
Number of subjects: 41

Group type: COMPARATOR
Intervention: No bright light therapy (no-BLT)
Number of subjects: 41